Finance

Lists
LH:NYSE
Labcorp Holdings Inc
312,15 $
-0,65%
(-2,05) 1D
311,84 $
-0,10% (-0,31)
After hours
Closed: 9 қаз., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
313,39 $
High
318,18 $
Low
311,62 $
Mkt. cap
25,32 млрд
Avg. vol.
776,61 м.
Volume
607,86 м.
Dividend
0,92%
Quarterly dividend
0,72 $
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
25,81
52-wk high
341,80 $
52-wk low
244,52 $
EPS
12,09 $
Beta
0,88
Shares outstanding
81,10 млн
No. of employees
71 мың
Open
313,39 $
High
318,18 $
Low
311,62 $
Mkt. cap
25,32 млрд
Avg. vol.
776,61 м.
Volume
607,86 м.
Dividend
0,92%
Quarterly dividend
0,72 $
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
25,81
52-wk high
341,80 $
52-wk low
244,52 $
EPS
12,09 $
Beta
0,88
Shares outstanding
81,10 млн
No. of employees
71 мың
News stories
From web sources and news partners
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71 мың
Founded1978
HeadquartersBurlington, Солтүстік Каролина, Америка Құрама Штаттары
SectorHealth care provider
Analyst ratings
Based on 13 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current 312,15 $
380,00 $ (+21,74%)
Average
343,50 $ (+10,04%)
Lowest
306,00 $ (-1,97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Hold
Maintained
330,00 $
+5,7%
10/07/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
David S Macdonald
Truist Financial
Buy
Maintained
365,00 $
+16,9%
09/21/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
340,00 $
+8,9%
09/11/2026
Kevin Caliendo
UBS
Buy
Maintained
380,00 $
+21,7%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
355,00 $
+13,7%
08/10/2026
David Westenberg
Piper Sandler
Hold
Reiterated
309,00 $
-1%
08/04/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
306,00 $
-2%
07/31/2026
Erin Wright
Morgan Stanley
Buy
Maintained
338,00 $
+8,3%
07/31/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
352,00 $
+12,8%
07/31/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
360,00 $
+15,3%
07/30/2026
David Toung
Argus Research
Buy
Maintained
310,00 $
-0,7%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
320,00 $
+2,5%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Last report
2026 ж. 30 шіл.
Fiscal period
Q2 2026
4,99 $ / 4,77 $
+4,65%beat
Revenue / Est. (USD)
3,73 млрд / 3,71 млрд
+0,47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
3,56 млрд
3,52 млрд
3,54 млрд
3,73 млрд
Cost of goods sold
2,54 млрд
2,52 млрд
2,52 млрд
2,62 млрд
Cost of revenue
2,54 млрд
2,52 млрд
2,52 млрд
2,62 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
552,40 млн
549,70 млн
551,00 млн
577,20 млн
Operating expense
621,90 млн
622,30 млн
626,60 млн
655,30 млн
Total operating expenses
3,16 млрд
3,14 млрд
3,15 млрд
3,27 млрд
Operating income
403,20 млн
370,90 млн
387,20 млн
456,70 млн
Other non operating income
700,00 м.
1,90 млн
-600,00 м.
-3,50 млн
EBT including unusual items
337,00 млн
190,60 млн
319,70 млн
386,40 млн
EBT excluding unusual items
341,30 млн
315,20 млн
333,20 млн
391,50 млн
Income tax expense
75,50 млн
25,70 млн
41,70 млн
87,30 млн
Effective tax rate
22,40%
13,48%
13,04%
22,59%
Other operating expenses
-
-
-
-
Net income
261,10 млн
164,70 млн
277,80 млн
298,70 млн
Net profit margin
7,33%
4,68%
7,85%
8,01%
Earnings per share
4,18
4,07
4,25
4,99
Interest and investment income
3,50 млн
3,50 млн
12,20 млн
5,60 млн
Interest expense
-56,00 млн
-55,00 млн
-55,10 млн
-61,10 млн
Net interest expenses
-52,50 млн
-51,50 млн
-42,90 млн
-55,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
574,20 млн
549,40 млн
560,50 млн
635,70 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары